Dysport in Lansing, MI
Dysport (abobotulinumtoxinA) is one of the most studied neurotoxins in aesthetic medicine, with a well-established safety record and a distinct clinical profile that sets it apart from other botulinum toxin formulations. At Maison Zolara, located at 4820 W Saginaw Hwy in west Lansing, our licensed RN clinicians perform every Dysport treatment under the clinical oversight of our on-staff Medical Director — giving patients in Lansing, Okemos, East Lansing, and the surrounding mid-Michigan communities access to a medically supervised injectable experience in a luxury setting.
Whether you're exploring neurotoxin injections for the first time or looking to switch from another product, this page covers everything you need to make an informed decision — from how Dysport works and what it treats, to realistic expectations around onset, duration, and cost.
- ✓Dysport (abobotulinumtoxinA)
- ✓FDA-approved neurotoxin
- ✓All skin types
- ✓MD-supervised
- ✓RN-performed
- ✓Free consultation
- ✓Member pricing available
How It Works
Dysport (abobotulinumtoxinA) is a prescription-only injectable neurotoxin derived from Clostridium botulinum type A. When injected into targeted facial muscles, it temporarily blocks the release of acetylcholine at the neuromuscular junction — the chemical signal that tells a muscle to contract. Without that signal, the muscle relaxes, and the overlying skin smooths.
The effect is temporary by design. Nerve terminals gradually regenerate their signaling capacity over several months, which is why repeat treatments are part of a long-term aesthetic plan rather than a one-time fix. According to data from the Galderma pivotal studies (GL-1, GL-2, and GL-3), results from a single Dysport treatment may last up to 5 months, with some patients in GL-1 and GL-3 evaluated for at least 150 days following treatment.
Clinical bottom line: Dysport works by temporarily relaxing the specific muscles responsible for dynamic wrinkles — lines that form from repeated facial expressions like frowning or squinting. It does not affect resting skin texture or static lines caused by volume loss; those concerns are better addressed with dermal fillers.
What It Treats
Dysport (abobotulinumtoxinA) is FDA-approved for the temporary improvement of moderate to severe glabellar lines (the "11" lines between the brows) in adults under 65. At Maison Zolara, our licensed RN clinicians also apply their expertise to other areas of the upper face where dynamic muscle activity creates visible lines.
Glabellar Lines
The vertical "11" lines between the eyebrows are the FDA-approved primary indication for Dysport. These form from repeated contraction of the corrugator and procerus muscles during frowning or concentrating.
Forehead Lines
Horizontal forehead creases caused by frontalis muscle activity respond well to neurotoxin treatment. Dosing in this area requires careful technique to preserve natural brow position.
Crow's Feet
The fan-shaped lines at the outer corners of the eyes develop from orbicularis oculi muscle contractions during smiling and squinting. Dysport's diffusion profile can be advantageous for treating this broader area.
Brow Lift
Strategic placement of small doses above the lateral brow can create a subtle, natural-looking lift by relaxing the depressor muscles that pull the brow downward.
Lip Lines
Fine vertical lines around the mouth (perioral lines) can be softened with conservative dosing, though this area requires an experienced injector to avoid affecting lip function.
Neck Bands
Platysmal bands — the vertical cords visible in the neck — can be relaxed with neurotoxin to create a smoother, more defined neck contour.
Dysport (abobotulinumtoxinA)
Dysport is manufactured by Galderma and is one of three FDA-approved botulinum toxin type A products available for cosmetic use in the United States. Understanding its specific characteristics helps set accurate expectations.
Formulation
Dysport contains abobotulinumtoxinA complexed with accessory proteins. The molecular complex is distinct from other neurotoxin formulations, which is why units are not interchangeable between products — a Dysport unit is not equivalent to a Botox unit, and dosing is always product-specific.
FDA Approval
Dysport received FDA approval for the treatment of moderate to severe glabellar lines in adults. Its approval is supported by multiple pivotal clinical trials (GL-1, GL-2, GL-3) demonstrating both efficacy and a favorable safety profile in the aesthetic indication.
Onset
According to Galderma's pivotal study data, some patients begin to see results as early as day 1 post-injection (15% in GL-1; 33% in GL-3). Most patients notice visible improvement within 2–3 days, with full effect typically apparent by day 14.
Duration
Results from a single treatment may last up to 5 months, based on GL-1 and GL-3 pivotal study data in which subjects were evaluated for at least 150 days following treatment. Individual duration varies based on muscle mass, metabolism, and treatment area.
Diffusion Profile
Dysport's smaller protein complex may result in slightly wider diffusion compared to some other neurotoxin formulations. According to a review published in Dermatology Times, researchers have not conclusively demonstrated that one product spreads more than another — but the diffusion characteristic is a clinical consideration that experienced injectors account for in their placement technique, particularly around the eyes and brow.
Unit Dosing
Because Dysport units are not interchangeable with other neurotoxin products, your injector will determine the appropriate Dysport-specific dose during your consultation. Typical cosmetic doses for glabellar lines range from 50 to 60 units of Dysport.
Dysport vs. Botox & Other Neurotoxins
The most common question patients ask is whether Dysport is "better than Botox." The honest answer is that both are effective, FDA-approved neurotoxins — and the best choice depends on your anatomy, treatment goals, and how your muscles have responded to previous treatments.
The table below provides a neutral, factual comparison of the three neurotoxin formulations available at Maison Zolara. Each has its own dedicated service page with full clinical detail.
| Feature | Dysport (abobotulinumtoxinA) | Botox (onabotulinumtoxinA) | Xeomin (incobotulinumtoxinA) |
|---|---|---|---|
| Manufacturer | Galderma | Allergan Aesthetics | Merz Aesthetics |
| FDA Cosmetic Approval | Glabellar lines | Glabellar lines, crow's feet, forehead | Glabellar lines |
| Typical Onset | 1–3 days | 3–5 days | 3–5 days |
| Typical Duration | Up to 5 months | 3–4 months | 3–4 months |
| Protein Complex | With accessory proteins | With accessory proteins | "Naked" toxin (no accessory proteins) |
| Unit Equivalence | Not interchangeable | Reference standard | Not interchangeable |
| Diffusion | Potentially wider spread | Moderate | Moderate |
Clinical note: According to a review in Dermatology Times citing Thomas E. Rohrer, M.D. of Boston University School of Medicine, "Recent studies show Botox and Dysport share more similarities than differences" — both are safe and effective when administered by a trained injector at appropriate doses.
Maison Zolara offers all three neurotoxins. Our licensed RN clinicians will discuss which formulation aligns best with your anatomy and goals during your complimentary consultation. Botox and Xeomin have their own dedicated pages.
Safety & Risks
Dysport (abobotulinumtoxinA) has a well-established safety profile when administered by trained clinicians at appropriate doses. Understanding both common and rare risks helps you make an informed decision.
FDA Boxed Warning — Distant Spread of Toxin Effect: The effects of Dysport and all botulinum toxin products may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. Symptoms have included asthenia, generalized muscle weakness, diplopia, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, and breathing difficulties. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening, and there have been reports of death. The risk of symptoms is probably greatest in children treated for spasticity, but symptoms can also occur in adults treated for spasticity and other conditions, particularly in those patients who have underlying conditions that would predispose them to these symptoms. In unapproved uses, including spasticity in children and adults, and in approved indications, cases of spread of effect have been reported at doses comparable to those used to treat cervical dystonia and at lower doses. ↗
Common side effects (typically mild and temporary):
- Injection site reactions: redness, swelling, bruising, tenderness
- Headache (reported in some patients in the days following treatment)
- Localized discomfort during injection
Less common but clinically important risks:
- Eyelid ptosis (drooping): Occurs in less than 1% of patients in aesthetic use, according to StatPearls/NCBI data. Risk is minimized by precise injection technique and avoiding the area directly above the eyelid.
- Brow ptosis: Can occur if the frontalis muscle is over-treated; experienced injectors account for this in dosing.
- Asymmetry: May occur and can often be corrected with a touch-up at the two-week follow-up.
- Bruising: Reported in 11–25% of patients receiving botulinum toxin injections, per NCBI StatPearls data. Avoiding blood thinners (including aspirin, ibuprofen, fish oil, and alcohol) for several days before treatment reduces this risk.
Contraindications include:
- Known hypersensitivity to botulinum toxin or cow's milk protein (Dysport contains lactose)
- Active infection at the proposed injection site
- Pregnancy or breastfeeding
- Neuromuscular conditions (e.g., myasthenia gravis, Lambert-Eaton syndrome)
- Concurrent use of aminoglycoside antibiotics, muscle relaxants, or other botulinum toxin products
All patients complete a thorough medical intake and are screened for contraindications before treatment. Our on-staff Medical Director provides clinical oversight of the treatment protocols used at Maison Zolara.
What to Expect
Here is a straightforward walkthrough of the Dysport treatment journey at Maison Zolara.
Before Your Treatment
Your first step is a complimentary consultation with one of our licensed RN clinicians. We review your medical history, discuss your aesthetic goals, assess your facial anatomy and muscle activity, and determine whether Dysport is the right neurotoxin for you. We'll discuss realistic expectations for onset, duration, and results — and answer every question you have, including concerns about looking "frozen" or overdone. You'll be asked to avoid blood thinners (aspirin, ibuprofen, fish oil, alcohol) for several days prior to your appointment to minimize bruising risk.
During Treatment
The appointment itself typically takes 15–30 minutes. Your injector will cleanse the treatment area and may apply a topical numbing agent if desired. Dysport is administered via a series of small, precise injections using a very fine needle. Most patients describe the sensation as a brief pinch. The number of injection points varies by treatment area and your individualized dosing plan. There is no sedation required, and you can drive yourself home.
After Treatment
You can return to most normal activities immediately. Avoid rubbing or massaging the treated area for 24 hours, avoid strenuous exercise and heat exposure (saunas, hot yoga) for 24 hours, and remain upright for at least 4 hours post-treatment. Most patients begin to notice results within 2–3 days, with full effect visible by day 14. We schedule a two-week follow-up to assess your results and address any asymmetry.
Aftercare
Proper aftercare protects your results and minimizes the risk of complications. The guidelines below apply to the first 24–48 hours following your Dysport treatment.
Following these simple guidelines helps ensure the product stays where it was placed and that your results develop as expected.
Pricing
Dysport (abobotulinumtoxinA) at Maison Zolara is priced per unit, making it transparent and easy to understand. The number of units required varies by treatment area and your individual anatomy — this is confirmed during your consultation.
- Standard pricing: From $13/unit
- Maison Circle member pricing: From $11/unit
Final pricing is always confirmed at your consultation, where your injector will assess the appropriate dose for your goals and anatomy. There is no obligation to book at your consultation.
Maison Circle members receive member pricing on Dysport and can track their treatment journey — including appointment history and upcoming sessions — in the Zolara Care app (available on the App Store).
Am I a Good Candidate?
Dysport is appropriate for a wide range of adults seeking to soften dynamic wrinkles caused by facial muscle movement. The following guide can help you assess fit before your consultation.
Most patients who are good candidates for Dysport are adults in good general health who have realistic expectations about what a neurotoxin can and cannot do. It softens dynamic lines — those caused by muscle movement — but does not address volume loss, skin laxity, or static lines at rest.
FAQ
Related Treatments
Botox in Lansing, MI
Botox (onabotulinumtoxinA) is the reference-standard neurotoxin for smoothing forehead lines, crow's feet, and glabellar lines. Compare Botox and Dysport side-by-side with our clinicians.
Xeomin in Lansing, MI
Xeomin (incobotulinumtoxinA) is a "naked" neurotoxin without accessory proteins — a consideration for patients who have developed resistance to other formulations.
Dermal Fillers in Lansing, MI
RHA Collection hyaluronic acid fillers restore volume, enhance lips, and contour the face — complementing neurotoxin treatments for a comprehensive facial rejuvenation approach.
RF Microneedling in Lansing, MI
Candela Matrix RF microneedling addresses skin texture, acne scars, and collagen remodeling — a powerful complement to neurotoxin treatments for overall skin quality.
Non-Surgical Skin Tightening
Candela Sublime technology delivers non-surgical skin tightening for mild laxity along the jawline and face — ideal for patients who want to address skin laxity alongside dynamic wrinkles.
Medical-Grade Skincare
Extend and enhance your Dysport results with Neocutis and other professional-grade skincare formulations available through Maison Zolara.
Serving the Greater Lansing Area
Maison Zolara is located at 4820 W Saginaw Hwy, in west Lansing along W Saginaw Hwy — easily accessible from across the greater mid-Michigan region. We serve patients from Lansing, East Lansing, Okemos, Holt, DeWitt, Grand Ledge, Mason, Charlotte, St. Johns, Williamston, and surrounding communities within a 30-mile radius.
Our clinic hours are 9:00 AM – 7:00 PM Monday through Friday, and 9:00 AM – 5:00 PM on Saturday. Free consultations are available — book online or call us to schedule.
Whether you're coming from Okemos for your first neurotoxin appointment or returning from DeWitt for a maintenance treatment, our team is here to provide a consistent, medically supervised experience in a welcoming west Lansing setting.
Clinical References
Galderma. Dysport® (abobotulinumtoxinA) Prescribing Information and Important Safety Information. https://www.dysportusa.com/hcp
Galderma. Dysport® Pivotal Studies GL-1, GL-2, GL-3 — Clinical Data Summary. https://www.dysportusa.com
Yin Y, et al. "Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Glabellar Lines in Chinese Patients: A Pivotal, Phase 3, Randomized, Double-Blind and Open-Label Phase Study." PubMed. 2022. https://pubmed.ncbi.nlm.nih.gov/36536093/
StatPearls. "Botulinum Toxin." NCBI Bookshelf. National Library of Medicine. https://www.ncbi.nlm.nih.gov/books/NBK557387/
StatPearls. "Botulinum Toxin Treatment of the Upper Face." NCBI Bookshelf. National Library of Medicine. https://www.ncbi.nlm.nih.gov/books/NBK574523/
Rohrer TE, et al. "Botox, Dysport Share More Similarities Than Differences, Studies Show." Dermatology Times. https://www.dermatologytimes.com/view/botox-dysport-share-more-similarities-differences-studies-show
Page Disclaimer: The information on this page is provided for educational purposes only and does not constitute medical advice. Clinical references are sourced from peer-reviewed research and named institutions as cited below. Individual results vary. Consult a qualified healthcare provider before beginning any treatment.
The Medical Director provides clinical oversight of treatments performed at this practice. The Medical Director does not author, review, or endorse website content.
Dysport® is a registered trademark of Galderma.